BMS-708163

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163

Drug-Drug Interaction Study With Rifampin

Multiple Dose Japanese Bridging Study

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Drug-Drug Interaction Study With Aricept® (Donepezil)

Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole

Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese

Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Drug Interaction Study With a Potential Alzheimer's Disease Compound